ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTR............................*XDIM350 (Ver 2.1 Jan 2001) 1100000/0 1710000/01429740A120040623EP01952549.22001071020040109EnEnEn20040623200426200406232004267 7A 61K 9/24 A 7A 61K 9/30 B 7A 61K 9/32 B 7A 61K 9/34 B 7A 61K 9/38 B 7A 61K 9/40 B 7A 61K 9/58 B 7A 61K 9/60 B 7A 61K 9/62 B 7A 61K 9/64 BdeKERNFORMULIERUNG MIT TROGLITAZON UND EINEM BIGUANIDenCORE FORMULATION COMPRISING TROGLITAZONE AND A BIGUANIDEfrFORMULATION DE NOYAU COMPRENANT DE LA TROGLITAZONE ET UN BIGUANIDEKos Life Sciences, Inc.04621930EP-14684/bu1001 Brickell Bay Drive25th FloorMiami, Florida 33131USADJEI, Akwete, L.15 Tillman CourtBridgewater, NJ 08807USZHU, Yaping29 van Wickle RoadEast Brunswick, NJ 08816USCUTIE, ANthony, J.10 Tillman CourtBridgewater, NJ 08807USForstmeyer, Dietmar, Dr. rer. nat., Dipl.-Chem.et al00077022Patentanwaltskanzlei Dr. Dietmar Forstmeyer,Bereiteranger 1581541 MünchenDEATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSETRALLTLVMKROSIUS200102161620010710EnWO200300599320030123200304